US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 2.330
  • -0.070-2.92%
Trading Jul 25 09:30 ET
60.42MMarket Cap-6297P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-41.89%1.66M
-27.61%2.76M
-2.62%2.54M
72.50%11.78M
7.26%2.49M
52.37%2.86M
255.99%3.81M
67.99%2.61M
89.03%6.83M
-6.41%2.33M
Selling and administrative expenses
-48.39%915.91K
-12.63%1.7M
-8.27%1.27M
59.79%6.18M
-10.78%1.08M
84.04%1.77M
126.43%1.94M
65.30%1.39M
187.97%3.87M
78.07%1.21M
-General and administrative expense
-48.39%915.91K
-12.63%1.7M
-8.27%1.27M
59.79%6.18M
-10.78%1.08M
84.04%1.77M
126.43%1.94M
65.30%1.39M
187.97%3.87M
78.07%1.21M
Research and development costs
-31.30%748.34K
-43.17%1.06M
3.80%1.27M
89.10%5.6M
26.74%1.42M
19.01%1.09M
778.16%1.87M
71.13%1.22M
30.46%2.96M
-38.11%1.12M
Operating profit
41.89%-1.66M
27.61%-2.76M
2.62%-2.54M
-72.50%-11.78M
-7.26%-2.49M
-52.37%-2.86M
-255.99%-3.81M
-67.99%-2.61M
-89.03%-6.83M
6.41%-2.33M
Net non-operating interest income expense
-89.40%8.39K
395.51%43.68K
55.2K
1,160.32%92.41K
6
79.15K
8.82K
0
168.22%7.33K
Non-operating interest income
-13.98%68.08K
756.65%75.52K
--55.2K
1,160.32%92.41K
--6
--79.15K
--8.82K
--0
618.82%7.33K
----
Non-operating interest expense
--59.7K
--31.84K
----
----
----
--0
--0
----
----
----
Other net income (expense)
117.74%2.32K
97.38%-594
3,511.79%7.66K
-2,215.48%-41.15K
73.92%-1.2K
-514.91%-13.08K
-1,111.66%-22.65K
-86.13%212
99.99%-1.78K
99.98%-4.59K
Other non- operating income (expenses)
117.74%2.32K
97.38%-594
3,511.79%7.66K
-2,215.48%-41.15K
73.92%-1.2K
-514.91%-13.08K
-1,111.66%-22.65K
-86.13%212
-32.22%-1.78K
-144.04%-4.59K
Income before tax
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
-68.14%-2.61M
77.44%-6.83M
92.02%-2.32M
Income tax
Net income
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
-68.14%-2.61M
77.44%-6.83M
92.02%-2.32M
Net income continuous Operations
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
-68.14%-2.61M
77.44%-6.83M
92.02%-2.32M
Minority interest income
Net income attributable to the parent company
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
-68.14%-2.61M
77.44%-6.83M
92.02%-2.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
-68.14%-2.61M
82.25%-6.83M
92.02%-2.32M
Basic earnings per share
45.45%-0.06
26.67%-0.11
9.09%-0.1
-62.07%-0.47
0.00%-0.1
-37.50%-0.11
-200.00%-0.15
-57.14%-0.11
89.75%-0.29
93.71%-0.1
Diluted earnings per share
45.45%-0.06
26.67%-0.11
9.09%-0.1
-62.07%-0.47
0.00%-0.1
-37.50%-0.11
-200.00%-0.15
-57.14%-0.11
89.75%-0.29
93.71%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -41.89%1.66M-27.61%2.76M-2.62%2.54M72.50%11.78M7.26%2.49M52.37%2.86M255.99%3.81M67.99%2.61M89.03%6.83M-6.41%2.33M
Selling and administrative expenses -48.39%915.91K-12.63%1.7M-8.27%1.27M59.79%6.18M-10.78%1.08M84.04%1.77M126.43%1.94M65.30%1.39M187.97%3.87M78.07%1.21M
-General and administrative expense -48.39%915.91K-12.63%1.7M-8.27%1.27M59.79%6.18M-10.78%1.08M84.04%1.77M126.43%1.94M65.30%1.39M187.97%3.87M78.07%1.21M
Research and development costs -31.30%748.34K-43.17%1.06M3.80%1.27M89.10%5.6M26.74%1.42M19.01%1.09M778.16%1.87M71.13%1.22M30.46%2.96M-38.11%1.12M
Operating profit 41.89%-1.66M27.61%-2.76M2.62%-2.54M-72.50%-11.78M-7.26%-2.49M-52.37%-2.86M-255.99%-3.81M-67.99%-2.61M-89.03%-6.83M6.41%-2.33M
Net non-operating interest income expense -89.40%8.39K395.51%43.68K55.2K1,160.32%92.41K679.15K8.82K0168.22%7.33K
Non-operating interest income -13.98%68.08K756.65%75.52K--55.2K1,160.32%92.41K--6--79.15K--8.82K--0618.82%7.33K----
Non-operating interest expense --59.7K--31.84K--------------0--0------------
Other net income (expense) 117.74%2.32K97.38%-5943,511.79%7.66K-2,215.48%-41.15K73.92%-1.2K-514.91%-13.08K-1,111.66%-22.65K-86.13%21299.99%-1.78K99.98%-4.59K
Other non- operating income (expenses) 117.74%2.32K97.38%-5943,511.79%7.66K-2,215.48%-41.15K73.92%-1.2K-514.91%-13.08K-1,111.66%-22.65K-86.13%212-32.22%-1.78K-144.04%-4.59K
Income before tax 40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M-68.14%-2.61M77.44%-6.83M92.02%-2.32M
Income tax
Net income 40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M-68.14%-2.61M77.44%-6.83M92.02%-2.32M
Net income continuous Operations 40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M-68.14%-2.61M77.44%-6.83M92.02%-2.32M
Minority interest income
Net income attributable to the parent company 40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M-68.14%-2.61M77.44%-6.83M92.02%-2.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M-68.14%-2.61M82.25%-6.83M92.02%-2.32M
Basic earnings per share 45.45%-0.0626.67%-0.119.09%-0.1-62.07%-0.470.00%-0.1-37.50%-0.11-200.00%-0.15-57.14%-0.1189.75%-0.2993.71%-0.1
Diluted earnings per share 45.45%-0.0626.67%-0.119.09%-0.1-62.07%-0.470.00%-0.1-37.50%-0.11-200.00%-0.15-57.14%-0.1189.75%-0.2993.71%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg